PTNNasdaqPharmaceutical PreparationsFiscal year ends June 30
PALATIN TECHNOLOGIES INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$5.99−0.03 (-0.50%)
Close on Oct 19, 2026
- Market cap
- $23.46M
- P/E (TTM)
- –
- Dividend yield
- –
PALATIN TECHNOLOGIES INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q4 23 | Q3 23 | Q2 23 | Q4 21 | Q3 21 | Q2 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patents And License [Member] | $2.34M | – | – | – | – | – | – | – | – | – | – | – | 2016.6% | – |
| FTE Reimbursements For Research And Development Services [Member] | $116.04K | – | – | – | – | – | – | – | – | – | – | – | 100.0% | – |
| License and Contract | – | – | – | – | – | – | – | – | – | $94.69K | $0 | $0 | – | – |
| Product Revenue [Member] | – | $0 | $0 | $2.11M | – | $0 | – | – | – | $80.50K | $88.74K | -$163.97K | – | – |
By region
From the segment and revenue-disaggregation notes of Palatin Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.